Isoxepac-d6
Isoxepac-d6 (HP 549-d6) is the deuterium labeled Isoxepac. Isoxepac (HP 549) is an orally active non-steroidal anti-inflammatory agent. Isoxepac can inhibit Carrageenan (HY-125474) paw oedema, adjuvant-induced polyarthritis, and prostaglandin synthesis. Isoxepac (200 mg) has an analgesic effect after meniscectomy with a low incidence of side effects. Isoxepac can be used in the research of inflammatory (rheumatoid arthritis) and pain-related diseases[1].
Product Specifications
CAS Number
2012598-71-7
Product Name Alternative
HP 549-d6
UNSPSC
12352005
Target
Drug Derivative; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others
Field of Research
Inflammation/Immunology; Neurological Disease
Solubility
10 mM in DMSO
Smiles
O=C1C2=CC(CC(O)=O)=CC=C2OC([2H])([2H])C3=C([2H])C([2H])=C([2H])C([2H])=C31
Molecular Formula
C16H6D6O4
Molecular Weight
274.30
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Fibronectin (HFN7.1), CF568 conjugate, 0.1mg/mL
Complement C4d (C4D204), CF488A conjugate, 0.1mg/mL
Cytokeratin, LMW (AE-1), CF740 conjugate, 0.1mg/mL
Histone H1 (AE-4), CF488A conjugate, 0.1mg/mL
CD54 / ICAM-1 (15.2), CF740 conjugate, 0.1mg/mL
